Two major private equity firms — Blackstone and TPG — are reportedly seeking more than $4 billion for the surgical division of medical technology company Hologic, according to a report published Thursday by the Financial Times, which cited sources with knowledge of the situation.
According to the FT, the two firms have brought in advisers to help facilitate a sale of the division, which manufactures surgical tools used by gynecologists.
Blackstone and TPG previously announced the acquisition of Hologic for $18.3 billion, funded through a combination of cash and debt, in what ranked as one of the largest buyouts ever recorded for a medical device company. That deal officially closed in April 2026.
The Financial Times reported that the private equity firms are now looking to use proceeds from a potential sale to reduce the debt taken on during the Hologic acquisition and return capital to their investors.
The planned divestiture is unfolding at a time when stress in the private credit market is beginning to ripple into related private equity markets, pushing firms to find new ways to generate cash for investors.
Blackstone, which operates among the major private credit funds, has recently faced its own pressure from investors seeking to withdraw funds. The firm reportedly capped withdrawals at its flagship private credit fund last month after a surge in redemption requests.
Reuters was unable to independently confirm the Financial Times report. Blackstone, TPG, and Hologic did not provide comment to Reuters before business hours ended.
